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http://www.diagnosticpathology.org/content/7/1/183CASE REPORT Open AccessPerivascular epithelioid cell neoplasm of the
urinary bladder in an adolescent: a case report
and review of the literature
Lijuan Yin1, Hong Bu1, Min Chen1, Jianqun Yu2, Hua Zhuang3, Jie Chen1 and Hongying Zhang1*Abstract: Perivascular epithelioid cell neoplasms (PEComas) of the urinary bladder are extremely rare and the
published cases were comprised predominantly of middle-aged patients. Herein, the authors present the first
urinary bladder PEComa occurring in an adolescent. This 16-year-old Chinese girl present with a 3-year history of
abdominal discomfort and a solid mass was documented in the urinary bladder by ultrasonography. Two years
later, at the age of 18, the patient underwent transurethral resection of the bladder tumor. Microscopically, the
tumor was composed of spindled cells mixed with epithelioid cells. Immunohistochemically, the tumor were
strongly positive for HMB45, smooth muscle actin, muscle-specific actin, and H-caldesmon. Fluorescence in situ
hybridization analysis revealed no evidence of EWSR1 gene rearrangement. The patient had been in a good status
without evidence of recurrence 13 months after surgery. Urinary bladder PEComa is an extremely rare neoplasm
and seems occur predominantly in middle-aged patients. However, this peculiar lesion can develop in pediatric
population and therefore it should be rigorously distinguished from their mimickers.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1870004378817301
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Perivascular epithelioid cell neoplasms (PEComas) are
defined by the World Health Organization as “mesenchy-
mal tumors composed of histologically and immunohisto-
chemically distinctive perivascular epithelioid cells” [1]. The
PEComa family of tumors includes angiomyolipoma
(AML), clear cell sugar tumor of the lung (CCST), lym-
phangioleiomyomatosis (LAM), and rare tumors in other
locations [2]. To date, non-AML/non-LAM/non-CCST
PEComas have progressively been documented in a variety
of anatomical sites, such as visceral organs, soft tissue and
bone [3-10]. However, only 12 cases of PEComas of the
urinary bladder have been documented in the English-
language literature worldwide [11-20]. Herein, we present a
urinary bladder lesion occurring in a Chinese adolescent.
To the best of our knowledge, the current case is the first* Correspondence: hy_zhang@scu.edu.cn
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reproduction in any medium, provided the orpublished example of bladder PEComa occurring in
pediatric population.Case presentation
A 16-year-old girl was referred to a peripheral hospital
with a 3-year history of vague abdominal discomfort. A
2.0-cm solid mass was identified in the urinary bladder by
ultrasonography. However, her parents preferred to
undergo regular follow-up examinations instead of mass
resection despite a recommendation. Two years later, at
the age of 18, the girl was admitted to our hospital with
1-month history of frequent micturition without
hematuria or dysuria. Her family history was unremark-
able, and no stigmata of tuberous sclerosis were detected.
Ultrasound and computed tomography (CT) scan demon-
strated a solid mass arising from the left posterior wall of
the bladder. Subsequent magnetic resonance imaging
(MRI) of the pelvis revealed a 2.5 × 2.2 cm2 sharply cir-
cumscribed soft tissue mass, with a wide base. The tumor
showed homogeneous intermediate signal intensity on the
T1-weighted images, slightly heterogeneous hyperintense. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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homogeneous enhanced signals on the T1-weighted
images (Figure 1). Cystoscopy demonstrated a yellowish
solid mass approximately 3 cm in diameter located in the
bladder wall, 2 cm below the left ureteral orifice, which
was partially protruding into the bladder lumen. Subse-
quently, the patient underwent transurethral resection of
the bladder tumor (TURBT). Both the intraoperative im-
pression and a postoperative ultrasound confirmed that
gross-total tumor resection had been achieved.
A fragmented specimen, 3 cm in aggregate, was sub-
jected to pathological examination. Histologically, the
tumor was composed of spindled cells mixed with epithe-
lioid cells arranged in fascicles or nests, with clear to lightly
eosinophilic cytoplasm (Figure 2A). Notably, an elaborate
capillary-sized vascular network was interspersed between
the cellular fascicles or nests (Figure 2B). The cellularity
was low to moderate. The tumor cells were generally bland
and uniform without prominent nuclear atypia or
increased mitotic activity (0/50 HPF). The nuclei were
round to oval in shape with inconspicuous nucleoli. Nei-
ther necrosis nor vascular invasion was observed. Further
immunohistochemical staining revealed that the neoplastic
cells were strongly positive for HMB45 (Figure 3A),
smooth muscle actin (SMA) (Figure 3B), muscle-specific
actin (MSA), and H-caldesmon. The neoplastic cells were
negative for the remaining antibodies, including Melan-A,
desmin, ALK-1, myogenin, S-100 protein, pan-cytokeratin
(AE1/AE3), TFE3, and EMA. Evaluation of proliferative ac-
tivity with MIB-1 LI was lower than 2% of the neoplastic
cells. Additionally, fluorescence in situ hybridization ana-
lysis revealed no evidence of 22q12 (EWSR1 gene) trans-
location, excluding the possibility of clear cell sarcoma ofFigure 1 Gd-enhanced coronal T1-weighted MRI showing
significantly inhomogeneously enhanced well-defined mass
with a wide base.soft tissue (CCSST). The histopathological features, to-
gether with immunohistochemical pattern and genetic
studies, indicated that the tumor was a PEComa.
The patient’s symptoms were almost relieved com-
pletely and she was discharged on the 5th postoperative
day. Six months later, a follow-up CT scan and ultra-
sound were normal. At the most recent follow-up
13 months following the surgery, the patient had been in
a good status without evidence of recurrence.
Discussion
PEComa belongs to a peculiar neoplasm and accounts
for an extremely smaller percentage of urinary bladder
mesenchymal lesions. A search of the English literature
indicated that only 12 previous cases of PEComas of the
urinary bladder have been reported thus far [11-20],
whereas two cases mentioned in Chinese-language lit-
eratures with English-language abstract were excluded
because of the unavailable detail information [21,22].
The clinicopathologic features of all published cases of this
kind of lesion are summarized in Table 1. Of the total of
13 cases, including the one in this context, the female-to-
male ratio was 6:7. The age of the patients ranged from 16
to 48 years (median: 36 years; average: 32.8 years). The
published cases seem to occur predominantly in middle-
aged patients. However, the current patient is the youngest
one and represents the first case involving the pediatric
patient although less than 40 pediatric PEComas have
been reported in other locations [23]. It is also noteworthy
to mention that this patient present with a 3-year history
of abdominal discomfort, implying that this lesion already
existed during childhood. Thus, urinary bladder PEComas
could develop very early in life. PEComas can arise from
any region of the bladder wall without overt anatomical
preference. All of the 13 bladder PEComas were solitary
lesions, although multifocal PEComas haven been deocu-
mented in other locations [24]. The tumor size of the 13
cases ranged from 2.5 to 9.2 cm (median: 3.7 cm; average:
4.3 cm). The clinical presentation comprised non-specific
urinary symptoms, such as hematuria, odynuria, and
vague abdominal pain. None of the patients was associated
with the tuberous sclerosis complex.
Microscopically, all of the 13 cases exhibited classic fea-
tures of PEComa, with admixture of epithelioid and
spindled cells arranged radially around blood vessels. Five
of 11 cases exhibited infiltrative growth pattern. The mi-
totic activity of all of the cases was no more than 1/50
HPF. Necrosis was found in 3 of 10 patients, although the
necrosis in 1 of the 3 cases might be attributed to prior
embolization [16]. Vascular invasion information was lim-
ited. Immunohistochemically, most cases exhibited co-
expression of melanotic and muscle markers, consistent
with immunophenotype of classic PEComa. Notably,
HMB45 was the most sensitive marker and all of the 13
Figure 2 Histologic features (Hematoxylin and eosin staining). A: The tumor consisting of spindled cells mixed with epithelioid cells,
exhibiting clear to lightly eosinophilic cytoplasm. (Original magnification: 200×). B: The neoplastic cells arranged around an elaborate capillary-
sized vascular network. (Original magnification: 100×).
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Diffuse immunoreactivity for SMA was observed in 91%
(10/11) of cases. In addition, neoplastic cells also showed
variable staining for other markers. For instance, Melan-
A, desmin, and S-100 protein expression was identified in
30% (3/10), 30% (3/10), 42% (5/12) of lesions, respectively.
The urinary bladder is an extremely rare location for
PEComa, especially for pediatric population. The differen-
tial diagnosis of this peculiar lesion is broad and some-
times might be very challenging especially in small biopsy
samples. This unique lesion must be differentiated from
melanotic tumors and other more common types of
pediatric bladder mesenchymal lesions, such as smooth
muscle tumors, rhabdomyosarcoma, and pseudosarcoma-
tous myofibroblastic proliferation.Figure 3 Immunohistochemical analysis. A: Positive staining for HMB45.
magnification: 200×).This unique lesion can be confused with CCSST and
melanoma because of the strong positivity for melanotic
markers, especially when neoplastic cells express S-100
protein. However, melanotic tumors can be distin-
guished from PEComa in several respects. First, cells of
melanotic neoplasms are characterized by large and con-
spicuous nucleoli. Second, strong S-100 protein expres-
sion is usually detected in most melanotic tumors but
only in a minority of PEComas [19]. Third, the majority
of PEComas also express muscle markers, whereas most
melanotic tumors are negative for actin. Fourth, and
most importantly, identification of t(12;22)(q13;q12)
(EWSR1-ATF1) or t(2;22)(q34;q12)(EWSR1/CREB1) fu-
sion can be invaluable in distinguishing CCSST from
PEComa [25].B: Positive staining for smooth muscle actin (SMA). (Original

















1 Pan 2003 [11] 33/F Symptomless Left lateral
inferior /4.0
W U 0 No U HMB45 (+), SMA (+), vimentin (−),
desmin (−),S-100 protein (−), Melan-A





19/F Hematuria Left lateral
/3.0
I High Few U U HMB45 (+), cytokeratin (−), S-100 (−),
synaptophysin (−), vimentin (−), desmin
(−), chromogranin A (−)
TURBT U








I High 0 Inconspicuous U HMB45 (+), Melan-A (+), SMA (+), desmin
(+), c-kit (+), S-100 protein (−), pan-
cytokeratin (AE1/AE3) (−), vimentin (−),

















High, focal Isolated Yes, focal No HMB45 (+), SMA (+), MSA (+), desmin
(+), Melan-A (+), S-100 protein (+), MiTF










1 No U HMB45 (+), S-100 protein (+), H-
caldesmon (+), actin (+), Melan-A (−),
CD34 (−), A103 (−), pankeratin (−),
calretinin (−), CD99 (−), ALK-1 (−), c-kit
(−), desmin (−)
Partial cystectomy ANEDx3
6 Sukov 2009 [16] 36/
M
Hematuria Anterior /4.8 I Low to
moderate
0 Yes, focal U HMB45 (+), SMA (+), tyrosinase (+),




Hematuria Dome /U W Low to
moderate
0 No U HMB45 (+), pan-cytokeratin (−), vimentin
(−), CD56 (−), chromogranin A (−),
Melan-A (−), S-100 protein (−),
synaptophysin (−), SMA (−), high-
molecular-weight cytokeratin (−), inhibin
(−)
TURBT ANEDx21
8 26/F U Anterior /5.0 W Low 0 Yes (related
to
embolization)
U HMB45 (+), SMA (+), vimentin (+), Melan-
A (−), tyrosinase (+), S-100 protein (−), c-











W Low 0 U U HMB45 (+), vimentin (+), SMA (+), S-100
protein (−), Melan-A (−), synaptophysin
(−), c-kit (−), CD34 (−), chromogranin A












<1 No U HMB45 (+), S-100 protein (+), MiTF (+),
SMA (+), calponin (+), vimentin (+),
desmin (−), myogenin (−),TFE3 (−), pan-
cytokeratin (AE1/AE3) (−), CD34 (−), ALK-




















Table 1 Reported cases of the urinary bladder PEComas in the English-Language Literature and their clinicopathologic features (Continued)
Left posterior
/2.7
















U U U U U HMB45 (+), Melan-A (+), SMA (+),
vimentin (+), MSA (+), S-100 protein (+),
cytokeratin (−), desmin(−)
TURBT ANEDx3




Posterior/2.5 W Low 0 No No HMB45 (+), SMA (+), MSA (+), desmin
(−), H-caldesmon (+), Melan-A (−), ALK-1
(−), myogenin (−), EMA (−), pan-
cytokeratin (AE1/AE3) (−), S-100 protein
(−), Ki-67 (+, 2%)
TURBT ANEDx13
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http://www.diagnosticpathology.org/content/7/1/183Smooth muscle tumors can mimic PEComa, as both
tumor types express muscle markers. Smooth muscle
tumors usually arrange in fascicles, demonstrating ‘cigar-
shaped’ nuclei and more eosinophilic cytoplasm. Immuno-
histochemically, the majority of smooth muscle tumors ex-
press strong positivity for desmin, whereas PEComas are
usually desmin-negative or express desmin only focally. It is
noteworthy to mention that very rare true smooth muscle
tumors can express HMB45 [26]; however, the staining is
focally and usually not strong, while most of PEComas usu-
ally show diffuse and strong HMB45 expression.
Both rhabdomyosarcoma and pseudosarcomatous myo-
fibroblastic proliferation are more common in this site, es-
pecially for very young patients. Additionally, these two
lesions express muscle markers. However, detailed mor-
phologic inspection combined with negativity for melan-
otic markers in these two lesions can be very valuable in
distinguishing them from PEComas [27-29].
Lastly, pediatric PEComas of the urinary system some-
times may be confused with renal carcinoma associated
with Xp11.2 translocations/TFE3 gene fusions, which usu-
ally affect children and young adults [30-32]. Of note, a
small minority of this peculiar renal carcinoma may dem-
onstrate immunoreactivity for HMB45 and is usually
negative for epithelial markers [30,32]. However, careful
morphologic inspection, in conjunction with the immu-
nostaining pattern and even genetic studies can be useful
in this differential diagnosis.
In 2005, a criterion for the classification of PEComas as
“benign”, “uncertain malignant potential” and “malignant”
was proposed by Folpe et al. [27]. Most PEComas behave
in a benign fashion and rare clinically malignant PEComas
with distant metastasis have been described [7-10,33]. Fol-
lowing this classification system suggested by Folpe et al.,
at least 4 of the cases (cases 2, 3, 4, and 6) could be classi-
fied as malignant lesions. However, based on the follow-up
information available in 9 of the cases (including 3 of the
malignant lesions), there have been no reports of recur-
rence or metastasis to date, implying that PEComas of
urinary bladder might be indolent. However, the following
factors need to be considered prior to drawing such a
conclusion. First, the number of cases was limited, and the
clinical follow-up period (average: 22.8 months; range:
3–72 months) of >12 months was available only in 5 cases
(average: 36.8 months; range: 13–72 months). Second,
whether the histological grade of urinary bladder PECo-
mas exhibits a linear association with their clinical behav-
ior remains unknown. Generally speaking, the behavior of
urinary bladder PEComas seems to be unpredictable, indi-
cating the necessity for the further investigation of more
cases with long-term follow-up.
Currently, the optimal treatment for PEComas is not
known. Among the 13 cases, 9 patients underwent partial
cystectomy and 4 of them received TURBT. Completeexcision seems to be curative and might be necessary to
avoid progression. Notably, 1 patient was treated by post-
operative adjuvant INF-α immunotherapy [13]. However,
further investigation is warranted to evaluate the efficacy
of adjuvant postoperative therapy in these unusual lesions.Conclusion
Urinary bladder PEComa is an extremely rare neoplasm
and usually occur in middle-aged patients. The present
case represents the first one occurring in an adolescent, in-
dicating that this peculiar lesion can affect pediatric popu-
lation. Therefore, pediatric bladder PEComa should be
rigorously distinguished from other more common types
of bladder lesions. Bladder PEComas exhibited classic fea-
tures of PEComa. All of the lesions seem to behave in an
indolent fashion although some tumors revealed malignant
morphology. Nonetheless,, the behavior of PEComa in this
site remains unpredictable. Further studies, including add-
itional large numbers of cases and longer-term follow-up
periods are necessary. Additionally, cytogenetic or molecu-
lar biological investigation is also warranted to better delin-
eate this peculiar lesion.Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
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